<DOC>
	<DOCNO>NCT00653419</DOCNO>
	<brief_summary>To compare single-dose bioavailability Par Bristol-Myers Squibb Buspirone HCl Tablets</brief_summary>
	<brief_title>Bioavailability Study ( Buspar ) Buspirone HCl Tablets Under Fasting Conditions</brief_title>
	<detailed_description>To compare single-dose bioavailability Par Bristol-Myers Squibb ( Buspar ) 15 mg Buspirone HCl Tablets fast condition , follow administration 30 mg dose</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Buspirone</mesh_term>
	<criteria>Healthy male volunteer , 1845 year age Weighing least 60 kg , within 10 % ideal weight ( Table `` Desirable Weights Adults '' , Metropolitan Life Insurance Company , 1983 ) Physical examination laboratory test hematologic , hepatic renal function Medically healthy subject clinically normal laboratory profile enrol study History presence significant cardiovascular , pulmonary , hepatic , renal , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic psychiatric disease The presence alcoholism drug abuse within past year Hypersensitivity idiosyncratic reaction buspirone HCl Subjects receive monoamine oxidase inhibitor Subjects abnormal diet ( whatever reason ) 28 day precede study Subjects , completion study , would donate excess 500 mL blood 14 day , 500750 mL blood 14 day ( unless approve Principal Investigator , 1000 mL blood 90 day , 1250 mL blood 120 day , 1500 mL blood 180 day , 2000 mL blood 270 day , 2500 mL blood 1 year Subjects participate another clinical trial within 28 day study start</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>bioequivalence</keyword>
	<keyword>buspirone HCl</keyword>
	<keyword>fast</keyword>
</DOC>